News
Videos
Conferences
Events
Resources
Subscribe

|Videos|June 29, 2022

Future Perspectives in Renal Cell Carcinoma (RCC)

Author(s)Thomas Hutson, DO, PharmD

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Episodes in this series

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Young adults with newly diagnosed cancer may feel overwhelmed, but open communication with doctors and support groups can help them feel less alone.

Finding Connection After a Young Adult Cancer Diagnosis

ByDisha Sawhney

November 17th 2025

Image of two men.

RAMPART Trial Highlights Kidney Cancer Treatment Options

ByDr. Joshua K. Sabari,Dr. Chandler Park

November 17th 2025

Image of kidney.

TKIs Take Lead After Immunotherapy in Metastatic Kidney Cancer

November 14th 2025

Generated by Google Gemini

Higher BMI Linked to Better Survival in Localized Kidney Cancer

BySpencer Feldman

November 14th 2025

American Indian and Alaskan Native individuals face some of the highest kidney cancer burdens in the United States: © stock.adobe.com.

Kidney Cancer Disparities Persist Among American Indian and Alaskan Native Patients

November 14th 2025

Trending on CURE

A Season to be Grateful as a Cancer Survivor

Targeted Ablation Therapy Improves Quality of Life in Pancreatic Cancer

The Sub-Q Therapy That Cut Hours Off Treatment Time

Marine Corps Veteran and Marathoner Ran Through Brain Cancer Journey

RAMPART Trial Highlights Kidney Cancer Treatment Options

© 2025 MJH Life Sciences^®

All rights reserved.